The BlueBarrier PFAS micropollutant treatment platform has been launched by Curio Water in response to increasing regulatory and operational pressure surrounding emerging contaminants in UK wastewater systems.
The containerised treatment train is designed to support removal of micropollutants and certain PFAS compounds from wastewater using a multi-stage treatment approach that combines several established water treatment technologies.
Curio Water said the platform was developed following increased enquiries from utilities seeking practical options for micropollutant and PFAS treatment as UK regulatory scrutiny continues to intensify.
Technology alliance targets complex wastewater contaminants
The BlueBarrier PFAS micropollutant treatment platform combines technologies from multiple engineering and treatment specialists to address a broad range of contaminants.
The treatment train includes ozone generation, oxygen production, ultrafiltration membranes, activated carbon systems and UV disinfection technologies.
According to Curio Water, the modular system is designed to adapt to varying wastewater characteristics and contaminant profiles between sites.
The company said every deployment would begin with a site-specific characterisation and feasibility phase using pilot-scale containerised systems before any permanent installation is developed.
PFAS and micropollutant regulation driving demand
The launch follows growing attention on micropollutants and PFAS compounds within the UK water sector.
The Cunliffe Review, published in 2025, identified PFAS, pharmaceuticals and microplastics as major long-term challenges facing water infrastructure and environmental protection.
Utilities across Europe and North America are increasingly evaluating advanced treatment technologies as policymakers and regulators consider tighter standards for emerging contaminants.
PFAS compounds, often referred to as “forever chemicals”, have become a particular focus because of their persistence in the environment and the technical challenges associated with removal and destruction.
What the BlueBarrier PFAS micropollutant treatment platform means for the sector
The BlueBarrier PFAS micropollutant treatment platform reflects a wider industry shift towards integrated treatment systems capable of targeting complex and evolving contaminant profiles.
Rather than relying on a single technology, utilities are increasingly exploring combined treatment approaches involving oxidation, filtration, adsorption and advanced polishing stages.
The use of containerised pilot systems also highlights the growing importance of feasibility testing and site-specific validation before utilities commit to large-scale infrastructure investment.
Water matrices can vary significantly depending on geography, industrial activity and wastewater composition, making tailored treatment sequencing increasingly important for future compliance strategies.
For more on PFAS treatment and emerging contaminant technologies, visit our Water Treatment coverage.
Research and engineering collaboration
The BlueBarrier alliance includes participation from Cranfield University, alongside engineering and treatment technology companies including Veolia Water Technologies, Statiflo, Desotec and UV Guard.
Curio Water said the collaboration was intended to combine engineering integration, treatment expertise and scientific validation within a single treatment framework.
The company also stated that the system is designed to support implementation within existing infrastructure where possible, potentially reducing the need for entirely new treatment facilities.
Further developments in PFAS removal and advanced treatment technologies can be explored in our Pollution section.
